Table 3.
Baseline and Final Values of Clinical Characteristics
| Glucose, mg/dL | HbA1c, % (mmol/mol) | |||||
|---|---|---|---|---|---|---|
| Baseline | Final | p | Baseline | Final | p | |
| Control group (n=43) | 157.3±47.6 | 157.2±38.2 | 0.194 | 8.86 (73) ±1.80 | 8.80 (73) ±1.34 | 0.436 |
| Intervention group (n=46) | 148.5±28.7 | 139.2±15.6 | <0.001 | 9.07 (73) ±1.76 | 7.6 (60) ±0.96 | <0.001 |
| SBP, mmHg | DBP, mmHg | |||||
| Baseline | Final | p | Baseline | Final | p | |
| Control group (n=43) | 140.95±13.7 | 141.14±13.1 | 0.782 | 92.26±6.12 | 92.91±6.25 | 0.425 |
| Intervention group (n=46) | 139.9±10.14 | 130.15±11.8 | <0.001 | 92.83±6.01 | 87±3.83 | <0.001 |
| Cholesterol, mg/dL | Triglycerides, mg/dL | |||||
| Baseline | Final | p | Baseline | Final | p | |
| Control group (n=43) | 171.62±30.5 | 169.2±27.4 | 0.007 | 162.95±45.9 | 158.5±39.7 | 0.049 |
| Intervention group (n=46) | 181.4±27.7 | 170.1±26.4 | <0.001 | 167.74±32.3 | 153.7±25.9 | <0.001 |
Notes: Mean ± SD. p≤ 0.05 values were considered statistically significant. Wilcoxon signed-rank test were used for comparison between baseline and final values.
Abbreviations: DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; SBP, systolic blood pressure; SD, standard deviation.